Leading up to hearing:
- After Becerra’s nomination was announced, Senator John Cornyn (R-TX) said the quiet part out loud when he admitted he preferred a Health secretary with ties to the pharmaceutical industry like Trump’s former HHS Secretary and former Pharma exec Alex Azar.
- Cornyn has taken over $1.7 million from the health sector, including $1 million from the pharmaceutical industry, and has frequently sided with the pharmaceutical industry in the past, including switching his vote to bring more affordable generic drugs to the market amid a fierce lobbying battle. Cornyn also gutted his own bill that would have allowed the FTC to go after pharmaceutical companies.
- Senator Mike Braun (R-IN) claimed to be concerned with whether Becerra would be willing to take on the health care industry — in direct contrast from Cornyn’s statements — ignoring his own ties to the industry and the hundreds of thousands of dollars he’s accepted over the course of his career. Braun later switched gears and tried out another line of attack in Becerra’s hearing, joining his colleagues in trying to paint Becerra as “extreme.”
- Braun has taken over $436,000 from the health industry, including over $105,000 from Big Pharma.
- In the early stages of Becerra’s nomination, Senator Rick Scott (R-FL) refused to answer whether he thought Becerra and other Biden nominees deserved a floor vote in the Senate. Before his career in politics, Scott was an executive at a health care company which was forced to pay $1.7 billion in fines after committing the nation’s largest health care fraud scheme at the time.
- Scott has taken nearly $1 million from the health sector, including over $101,000 from the pharmaceutical industry.
- Heritage Action for America, a far-right group with a track record of working on behalf of PhRMA, including advocating against lowering the cost of prescription drugs, released a $500,000 ad buy to oppose Becerra’s confirmation.
- Heritage has taken at least $375,000 from PhRMA and does their bidding in Washington.
- Minority Leader Mitch McConnell obstructed the confirmation process by delaying a simple organizing resolution for weeks, halting committees’ important work and leaving Becerra’s confirmation at a standstill.
- McConnell has taken over $9 million from the health sector, including over $1.7 million from the pharmaceutical industry.
- Senator Rand Paul (R-KY) objected to Becerra’s nomination from nearly the moment it was announced, and used Fox News to propagateextreme and inaccurate claims about Becerra’s positions on reproductive health.
- Paul has taken over $2 million from the health sector, including over $132,000 from the pharmaceutical industry.
- Senator Chuck Grassley (R-IA) flat out rejected any possibility of a speedy confirmation process for then President-elect Biden’s nominees while Republicans still had control of the Senate during the lame-duck period, slowing the entire process down and preventing the new administration from being able to hit the ground running.
- Grassley has taken over $3.7 million from the health sector, including nearly $1 million from the pharmaceutical industry.
- Senator Tom Cotton (R-AR) released false and misleading attack ads regarding Becerra’s record in Georgia and New Hampshire on behalf of his special interest donors.
- Cotton has taken over $121,000 from the pharmaceutical industry and over $422,000 from the insurance industry
- Accountable Senate War Room responded to Sen. Cotton’s bad-faith attacks to set the record straight in an ad that exposed his loyalty to Big Pharma.
- Senator Ted Cruz (R-TX) tweeted his opposition to the nominee, claiming his concern with Becerra was because “he’s never worked at a pharmaceutical company.” Cruz voted in support of President Trump’s nominee for HHS Secretary, Alex Azar, a former lawyer and Big Pharma executive.
- Cruz has taken over $5.7 million from the health sector, including over $605,000 from the pharmaceutical industry.
During Hearing:
- Senator John Thune (R-SD) referred to Becerra as “an extremist.”
- Thune has taken over $2.4 million from the health sector, including over $410,000 from the pharmaceutical industry.
- Senator Richard Burr (R-NC) questioned Becerra’s qualifications, stating, “I am not sure that you have the appropriate respect for the private sector and innovation and intellectual property needed to bring more exciting treatments and cures to save lives in this country.” Burr, who was recently under federal investigation for insider trading, has been accused of “pay-to-play” politics by ProPublica who named him “one of the health care industry’s staunchest friends” by consistently pushing legislation to benefit them — including overseeing “the implementation of major legislation to pump taxpayer money into private sector initiatives to address public health threats.”
- Burr has taken over $4.8 million from the health sector, including over $1.5 million from the pharmaceutical industry.
- Senator Ben Sasse (R-NE) made a show out of his questioning when he aggressively questioned Becerra’s role in a lawsuit involving an order of nuns, claiming they were forced to pay for contraceptives — an issue that has been referred to as a “bald-faced lie” by the LA Times.
- Sasse has received over $723,000 from the health sector, including over $205,000 from the pharmaceutical industry.
Accountable Senate War Room has been holding Senate Republicans accountable throughout Becerra’s confirmation process. Below are some examples of that work:
- Senator Cornyn Admits He Believes Health Secretary Should Be In The Pocket of Big Pharma [Dec. 8, 2020]
- After Overseeing Biggest Medicare Fraud In History, Sen Scott Doesn’t Want to Vote on Health Nominee That Would Crack Down on Medicare Fraud [Dec. 9, 2020]
- ROUNDUP: As Republican Leaders Refuse to Acknowledge President-Elect Biden’s Win, Senators Start Attacking Biden’s Health Nominee On Behalf of Big Pharma Allies [Dec. 11, 2020]
- MEMO: Continued Delays to Confirmation Process of Biden Nominees Are A Threat to National Security and Public Safety [Jan. 11, 2021]
- New Report Highlights How Delays of Health Secretary Could Impede Administration’s Ability To Fight COVID-19 Pandemic [Jan. 28, 2021]
- NEW–TEXAS BACKGROUND: As COVID Numbers Climb, Senator Cornyn Chooses Big Pharma Over Texans [Feb. 3, 2021]
- 60 Days of Delay and Counting: As Pandemic Rages On, Senate Republicans Obstruct Biden’s Health Secretary Nominee [Feb. 4, 2021]
- Senate Republicans Choose Special Interests Over American People with Plans to Obstruct Becerra’s Confirmation Amid Global Pandemic[Feb. 10, 2021]
- Sebelius, ER Doctor Discuss How Senate Republicans’ Efforts to Oppose Health Secretary Will Hinder COVID-19 Response [Feb. 12, 2021]
- Heritage Action to GOP Senators: Put PhRMA Interests Ahead of Constituents and Effective COVID-19 Response [Feb. 19, 2021]
- With 500,000 Lives Lost, GOP Senators Eager to Block Biden’s HHS Pick[Feb. 22, 2021]
- NEW REPORT: Sen. Burr Raked in Money from Health Care Special Interests While Poised to Chair Key Committee [Feb. 23, 2021]
- NEW REPORT: Sen. Crapo Raked in Money from Health Care and Financial Special Interests While Poised to Chair Key Committee [Feb. 23, 2021]
- ROUND-UP: GOP Senators Attack Becerra, Haaland to Prove Loyalty to Special Interests [Feb. 24, 2021]
- New Analysis Shows Senators Cast Cabinet Nominees of Color as “Radical,” But Use Softer Language for White Nominees [Feb. 26, 2021]
- New Ad: Accountable.US Responds to Sen. Cotton’s Anti-Becerra Campaign, Exposes His Loyalty to Big Pharma [March 1, 2021]
- As Finance Committee Votes on Becerra Nomination, Opposition is Coming From Members Who Have Taken $9.6 Million from Big Pharma[March 3, 2021]
|